NCT05341973

Brief Summary

The purpose of this research; The aim of this study is to examine the effects of self-management support given for hypertension patients on patients' adherence to treatment and disease, self-efficacy level, self-care management. This research is a randomized controlled and pretest-posttest applied design. The research will be carried out in Van Yüzüncü Yıl University Research Hospital with patients previously diagnosed with hypertension. The population of the research will consist of patients who have previously applied to the hospital where the research will be conducted and who have been diagnosed with hypertension who meet the research criteria. After the power analysis, it is planned to include 150 hypertension patients in the sample of the study. All patients in the intervention and control groups who meet the inclusion criteria will be verbally informed about the purpose of the study and the method of application, and their consent will be obtained. The pretest forms required for the research will be filled in by face-to-face interview method for all patients. In the study, the number of individuals in the randomization group will be determined by using the computer program, provided that they are equal in number. All materials prepared for self-management support will be delivered to the patients in the intervention group and they will be taught how to use them by the demonstration method. Patients will be asked to do the same procedure and the process will continue until they ensure correct use. Participants will be informed that there is a phone number that they can call whenever they want, when there are subjects that are not understood or that need to be repeated. Patients will be called three times a week and necessary checks will be made on blood pressure monitoring, nutrition, weight control, etc. In this way, patients in the intervention group will be followed remotely by tele-nursing for 3 months, their questions will be answered when they encounter problems, and guidance will be given in case of emergency. No intervention will be made in the control group. Necessary forms will be re-administered to all patients in both groups after 3 months as a post-test. At the end of the research, a comparison of the intervention and control groups will be made.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 13, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 22, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 22, 2022

Status Verified

April 1, 2022

Enrollment Period

4 months

First QC Date

April 13, 2022

Last Update Submit

April 21, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-Care Management Scale in Chronic Diseases (KHÖBYÖ)

    he scale consists of 35 items and is in a five-point Likert type (1 = strongly disagree, 2 = disagree, 3 = undecided, 4 = agree, 5 = strongly agree). Self- protection (items 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and social protection (1, 3, 4, 5, 7, 9, 10, 12) There are two sub-dimensions (items 13, 14, 16, 17, 21, 24 and 35). Items 3, 15, 19 and 28 in the scale are negative statements. The total scores that can be obtained from the scale vary between 35-175 points, and an increase in the score indicates that the individual's self-care management also increases.

    3months

  • The 6-item Self-Efficacy for Managing Chronic Diseases Scale(SEMCD6)

    It is an easy-to-use and effective tool for assessing the self-efficacy levels of patients with chronic diseases. The scale is rated on a 10-point scale ranging from "not at all sure" to "very sure". The score obtained from the scale is the average of 6 items, and high scores indicate high self-efficacy. If more than 1 answer is given to an item and the items are consecutive, the low score is included in the calculation. If the 2 answers given are not consecutive, this item is excluded from the calculation. In order for the scale to be calculated, at least 4 items must be answered.

    3months

Study Arms (2)

Education

EXPERIMENTAL

The Self- Management Program Developed will increase Self-Efficacy, Self-Care Management in Hypertension Patients.

Behavioral: Education

Control

NO INTERVENTION

It will not change the Self-Efficacy, Self-Care Management in Hypertension Patients of the Self-Management Program.

Interventions

EducationBEHAVIORAL

Self-Management Program will increase Self-Efficacy, Self-Care Management in Hypertension Patients.

Education

Eligibility Criteria

Age18 Years - 72 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Follow-up for at least 6 months with the diagnosis of essential hypertension,
  • Using antihypertensive drugs,
  • No change in antihypertensive drug treatment in the last 1 month,
  • Not having any other accompanying chronic disease (Diabetes mellitus, cancer, chronic -kidney failure, chronic obstructive pulmonary disease, heart failure, etc.),
  • Having no mental or communication problems,
  • Computer/tablet/smartphone etc. to watch videos. having technological tools,
  • Having internet,
  • Being over 18 years old,
  • Having at least primary education level, Not being pregnant or lactating,

You may not qualify if:

  • Follow-up for less than 6 months with the diagnosis of essential hypertension,
  • Not using antihypertensive drugs,
  • Changes in antihypertensive drug therapy in the last 1 month,
  • Presence of another concomitant chronic disease (Diabetes mellitus, cancer, chronic -kidney failure, chronic obstructive pulmonary disease, heart failure, etc.),
  • Having a mental or communication problem,
  • Computer/tablet/smartphone etc. to watch videos. lack of technological tools,
  • Lack of internet,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BAHAR Çiftçi

Erzurum, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Hypertension

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • BAHAR Çiftçi

    Ataturk University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 13, 2022

First Posted

April 22, 2022

Study Start

March 1, 2022

Primary Completion

July 1, 2022

Study Completion

December 1, 2022

Last Updated

April 22, 2022

Record last verified: 2022-04

Locations